They address the biological drivers of obesity appetite hormones, gastric emptying, and central reward circuits that diet and exercise alone often cannot overcome
Latin America Market Insight : Latin Americas rising focus on obesity prevention and healthy lifestyle choices has led to increased interest in supplements like GLP-1 boosters to aid weight loss and metabolic health
Weight Loss Potential : The GLP-1 Protocol typically leads to up to 15% body weight reduction, while the Advanced GLP-1 Protocol leads to up to 20-22% body weight reduction, offering enhanced results for some patients
And Novo Nordisk is asking the U.S
This isnt just about a drug that works, its about a drug that works for something that has reached the status of epidemic in most developed markets
doi: 10.1038/oby.2010.147 30 Gadde KM, Allison DB, Ryan DH, et al